How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID).
Autor: | Dema E; Institute for Global Health, University College London, London, UK emily.dema.19@ucl.ac.uk., Sonnenberg P; Institute for Global Health, University College London, London, UK., Gibbs J; Institute for Global Health, University College London, London, UK., Conolly A; Institute for Global Health, University College London, London, UK.; Health and Biomedical Surveys, NatCen Social Research, London, UK., Willis M; Social and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK., Riddell J; Social and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK., Bosó Pérez R; Social and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK., Copas AJ; Institute for Global Health, University College London, London, UK., Tanton C; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK., Bonell C; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK., Oeser C; Institute for Global Health, University College London, London, UK., Clifton S; Institute for Global Health, University College London, London, UK.; Health and Biomedical Surveys, NatCen Social Research, London, UK., Unemo M; Department of Laboratory Medicine, Örebro University Hospital, Orebro, Sweden., Mercer CH; Institute for Global Health, University College London, London, UK., Mitchell KR; Social and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK., Field N; Institute for Global Health, University College London, London, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Sexually transmitted infections [Sex Transm Infect] 2023 Jun; Vol. 99 (4), pp. 261-267. Date of Electronic Publication: 2022 Aug 18. |
DOI: | 10.1136/sextrans-2022-055516 |
Abstrakt: | Objectives: To investigate how differential access to key interventions to reduce STIs, HIV and their sequelae changed during the COVID-19 pandemic. Methods: British participants (18-59 years) completed a cross-sectional web survey 1 year (March-April 2021) after the initial lockdown in Britain. Quota-based sampling and weighting resulted in a quasi-representative population sample. We compared Natsal-COVID data with Natsal-3, a household-based probability sample cross-sectional survey (16-74 years) conducted in 2010-2012. Reported unmet need for condoms because of the pandemic and uptake of chlamydia testing/HIV testing/cervical cancer screening were analysed among sexually experienced participants (18-44 years) (n=3869, Natsal-COVID; n=8551, Natsal-3). ORs adjusted for age and other potential confounders describe associations with demographic and behavioural factors. Results: In 2021, 6.9% of women and 16.2% of men reported unmet need for condoms because of the pandemic. This was more likely among participants: aged 18-24 years, of black or black British ethnicity, and reporting same-sex sex (past 5 years) or one or more new relationships (past year). Chlamydia and HIV testing were more commonly reported by younger participants, those reporting condomless sex with new sexual partners and men reporting same-sex partners; a very similar distribution to 10 years previously (Natsal-3). However, there were differences during the pandemic, including stronger associations with chlamydia testing for men reporting same-sex partners; with HIV testing for women reporting new sexual partners and with cervical screening among smokers. Conclusions: Our study suggests differential access to key primary and secondary STI/HIV prevention interventions continued during the first year of the COVID-19 pandemic. However, there was not strong evidence that differential access has changed during the pandemic when compared with 2010-2012. While the pandemic might not have exacerbated inequalities in access to primary and secondary prevention, it is clear that large inequalities persisted, typically among those at greatest STI/HIV risk. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.) |
Databáze: | MEDLINE |
Externí odkaz: |